| 000 | 01690 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516070202.0 | ||
| 264 | 0 | _c20120709 | |
| 008 | 201207s 0 0 eng d | ||
| 022 | _a1463-1326 | ||
| 024 | 7 |
_a10.1111/j.1463-1326.2011.01548.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGonçalves, A | |
| 245 | 0 | 0 |
_aProtective effects of the dipeptidyl peptidase IV inhibitor sitagliptin in the blood-retinal barrier in a type 2 diabetes animal model. _h[electronic resource] |
| 260 |
_bDiabetes, obesity & metabolism _cMay 2012 |
||
| 300 |
_a454-63 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aBlood-Retinal Barrier _xdrug effects |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xdrug therapy |
| 650 | 0 | 4 |
_aDiabetic Retinopathy _xdrug therapy |
| 650 | 0 | 4 |
_aDipeptidyl-Peptidase IV Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xdrug effects |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aIn Situ Nick-End Labeling |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPyrazines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Zucker |
| 650 | 0 | 4 | _aSitagliptin Phosphate |
| 650 | 0 | 4 |
_aTriazoles _xpharmacology |
| 700 | 1 | _aLeal, E | |
| 700 | 1 | _aPaiva, A | |
| 700 | 1 | _aTeixeira Lemos, E | |
| 700 | 1 | _aTeixeira, F | |
| 700 | 1 | _aRibeiro, C F | |
| 700 | 1 | _aReis, F | |
| 700 | 1 | _aAmbrósio, A F | |
| 700 | 1 | _aFernandes, R | |
| 773 | 0 |
_tDiabetes, obesity & metabolism _gvol. 14 _gno. 5 _gp. 454-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1463-1326.2011.01548.x _zAvailable from publisher's website |
| 999 |
_c21375223 _d21375223 |
||